$CBRE

CBRE GROUP, INC.

No enriched coverage for $CBRE in the last 7 days.

No SEC Form 4 filings for $CBRE in the last 30 days.

Med

CBRE (NYSE: CBRE) CFO trims stake with 2,250-share sale

CBRE Group, Inc.'s CFO and Chief Investment Officer, Emma E. Giamartino, reported an open-market sale of 2,250 shares of Class A Common Stock at $130.74 per share. Following this transaction, Giamartino directly holds 110,729 shares of CBRE common stock. The sale, made pursuant to a 10b5-1 plan, amounted to approximately $294,165.

Vanguard reports 21.96M-share stake in CBRE (NYSE: CBRE)

Vanguard Capital Management has reported a 7.43% stake in CBRE Group Inc., holding 21,955,428 common shares as of March 31, 2026. This passive investment, disclosed via a Schedule 13G filing, indicates Vanguard exercises sole voting power over 2,904,409 shares and sole dispositive power over all 21,955,428 shares. The filing underscores Vanguard's position as a significant passive shareholder without an activist intent.

[SCHEDULE 13G] CBRE GROUP, INC. Passive Investment Disclosure (>5%)

Vanguard Portfolio Management has filed a Schedule 13G for CBRE Group Inc, disclosing beneficial ownership of 25,848,219 shares, which represents 8.75% of the common stock. This filing indicates that Vanguard holds sole voting power for 40,669 shares and sole dispositive power for all 25,848,219 shares. The disclosure also confirms that no other single person's interest in the reported securities exceeds 5%.

News on $CBRE